Search
10/06/2024
KROCUS: A phase II study investigating the efficacy and safety of fulzerasib (GFH925) in combination with cetuximab in patients with previously untreated advanced KRAS G12C mutated NSCLC.
Gregorc, V, González-Cao, M, Salvagni, S, Koumarianou, A, Gil-Bazo, I, Maio, M, Viteri, S, Majem, M, Gutiérrez, V, Caro, RB, Sanmamed, MF, Zhu, HQ, Shen, HG, Wang, Y, Rosell, R. KROCUS: A phase II study investigating the efficacy and safety of fulzerasib (GFH925) in combination with cetuximab in patients with previously untreated advanced KRAS G12C mutated NSCLC.. JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(17_SUPPL)DOI:10.1200/JCO.2024.42.17_suppl.LBA8511. PMID:. IF:41.900(Q1/1D).
10/06/2024
Left Atrial Appendage Occlusion in Patients With Anticoagulation Failure vs Anticoagulation Contraindication
Aarnink, EW, Maarse, M, Fierro, N, Mazzone, P, Beneduce, A, Tondo, C, Gasperetti, A, Pracon, R, Demkow, M, Zielinski, K, de Backer, O, Korsholm, K, Nielsen-Kudsk, JE, Estévez-Loureiro, R, Caneiro-Queija, B, Benito-González, T, de Prado, AP, Nombela-Franco, L, Salinas, P, Holmes, D, Almakadma, AH, Berti, S, Romeo, MR, Millan, X, Arzamendi, D, Alla, VM, Agarwal, H, Eitel, I, Paitazoglou, C, Freixa, X, Cepas-Guillén, P, Chothia, R, Badejoko, SO, Spoon, DB, Maddux, JT, El-Chami, M, Ram, P, Branca, L, Adamo, M, Suradi, HS, Peper, J, van Dijk, VF, Rensing, BJWM, Swaans, MJ, Vireca, E, Bergmann, MW, Boersma, LVA. Left Atrial Appendage Occlusion in Patients With Anticoagulation Failure vs Anticoagulation Contraindication. JACC-Cardiovascular Interventions. 2024; 17(11)DOI:10.1016/j.jcin.2024.04.012. PMID:38795093. IF:11.400(Q1/1D).
08/06/2024
Increased grey matter volumes in the temporal lobe and its relationship with cognitive functioning in euthymic patients with bipolar disorder
Porta-Casteràs, D, Vicent-Gil, M, Serra-Blasco, M, Navarra-Ventura, G, Solé, B, Montejo, L, Torrent, C, Martinez-Aran, A, de la Peña-Arteaga, V, Palao, D, Vieta, E, Cardoner, N, Cano, M. Increased grey matter volumes in the temporal lobe and its relationship with cognitive functioning in euthymic patients with bipolar disorder. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2024; 132DOI:10.1016/j.pnpbp.2024.110962. PMID:38365103. IF:3.900(Q1/2D).
07/06/2024
Impact of the use of plaque modification techniques on coronary microcirculation using an angiography-derived index of microcirculatory resistance
Calderón, AT, Sans-Roselló, J, Fernández-Peregrina, E, Sánchez, JS, Bosch-Peligero, E, Sánchez-Ceña, J, Romero, JS, Valcárcel-Paz, D, Jiménez-Kockar, M, Gil, JLD, Asmarats, L, Millan-Alvarez, X, Vilchez-Tschischke, JP, Martinez-Rubio, A, Garcia-Garcia, HM. Impact of the use of plaque modification techniques on coronary microcirculation using an angiography-derived index of microcirculatory resistance. INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING. 2024; 40(8)DOI:10.1007/s10554-024-03152-5. PMID:38848005. IF:1.500(Q3/7D).
06/06/2024
DNA methylation and stroke prognosis: an epigenome-wide association study
Jiménez-Balado, J, Fernández-Pérez, I, Gallego-Fábrega, C, Lazcano, U, Soriano-Tárraga, C, Vallverdú-Prats, M, Mola-Caminal, M, Rey-Alvarez, L, Macias-Gómez, A, Suárez-Pérez, A, Giralt-Steinhauer, E, Rodríguez-Campello, A, Cuadrado-Godia, E, Ois, A, Esteller, M, Roquer, J, Fernández-Cadenas, I, Jiménez-Conde, J. DNA methylation and stroke prognosis: an epigenome-wide association study. Clinical Epigenetics. 2024; 16(1)DOI:10.1186/s13148-024-01690-2. PMID:38845005. IF:4.400(Q1/2D).
05/06/2024
Clinicopathological correlates in the frontotemporal lobar degeneration-motor neuron disease spectrum
Carbayo, A, Borrego-Écija, S, Turon-Sans, J, Cortés-Vicente, E, Molina-Porcel, L, Gascón-Bayarri, J, Rubio, MA, Povedano, M, Gámez, J, Sotoca, J, Juntas-Morales, R, Almendrote, M, Marquié, M, Sánchez-Valle, R, Illán-Gala, I, Dols-Icardo, O, Rubio-Guerra, S, Bernal, S, Caballero-Avila, M, Vesperinas, A, Gelpi, E, Rojas-García, R. Clinicopathological correlates in the frontotemporal lobar degeneration-motor neuron disease spectrum. BRAIN. 2024; 147(7)DOI:10.1093/brain/awae011. PMID:38227807. IF:11.700(Q1/1D).